Agency Forms Undergoing Paperwork Reduction Act Review, 78924-78925 [2011-32495]
Download as PDF
<![CDATA[
78924
Federal Register / Vol. 76, No. 244 / Tuesday, December 20, 2011 / Notices
operators, replacing the requirement of
a letter containing approximately the
same information. Every Form 324 filing
will require information about the
system—the additional information
required depending largely upon the
nature of the change.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Federal Communications Commission.
Bulah P. Wheeler,
Deputy Manager, Office of the Secretary,
Office of Managing Director.
Agency Forms Undergoing Paperwork
Reduction Act Review
[FR Doc. 2011–32463 Filed 12–19–11; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL RESERVE SYSTEM
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
jlentini on DSK4TPTVN1PROD with NOTICES
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than January 4, 2012.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. First Mutual of Richmond, Inc., and
Richmond Mutual Bancorp, Inc., both
in, Richmond, Indiana; to engage de
novo in lending activities, pursuant to
section 225.28(b)(1) of Regulation Y.
Board of Governors of the Federal Reserve
System, December 15, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011–32517 Filed 12–19–11; 8:45 am]
BILLING CODE 6210–01–P
VerDate Mar<15>2010
16:28 Dec 19, 2011
Jkt 226001
Centers for Disease Control and
Prevention
[30-Day-12–11DT]
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Monitoring Outcomes of the
Enhanced Comprehensive HIV
Prevention Plan (ECHPP) Project -NewNational Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The scope of the HIV epidemic in the
United States is significant, particularly
in large urban areas where HIV/AIDS
cases are concentrated. In 2006,
approximately 56,000 new HIV
infections occurred in the U.S.,
demonstrating the need to expand
targeted HIV prevention efforts. In 2010,
twelve U.S. metropolitan statistical
areas (MSAs) received funding, through
their city and state health departments,
to conduct the Enhanced
Comprehensive HIV Prevention
Planning (ECHPP) project. These twelve
MSAs (Atlanta, GA; Baltimore, MD;
Chicago, IL; Dallas, TX; District of
Columbia; Houston, TX; Los Angeles,
CA; Miami, FL; New York City, NY;
Philadelphia, PA; San Francisco, CA;
and San Juan, PR) had the highest AIDS
prevalence rates in the U.S. at the end
of 2007, representing 44% of all U.S.
AIDS cases. The purpose of ECHPP is to
enhance existing HIV prevention
services in these high prevalence areas
and provide an optimal mix of
evidence-based behavioral, biomedical,
and structural interventions to have
maximum impact on the HIV/AIDS
epidemic at the community level.
ECHPP goals are consistent with CDC’s
Division of HIV/AIDS Prevention
Strategic Plan for HIV Prevention and
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
with the National HIV/AIDS Strategy:
(1) Prevent new HIV infections, (2)
increase linkage to, and impact of,
prevention and care services for HIVpositive individuals, and (3) reduce
HIV-related health disparities.
To evaluate ECHPP’s impact on the
HIV/AIDS epidemic at the community
level, data will be collected through
both existing CDC data sources and
through new data collection activities.
Existing CDC data sources will include
HIV surveillance systems (e.g., National
HIV Behavioral Surveillance System,
Medical Monitoring Project) that
routinely collect information about
behavioral and clinical outcomes from
at-risk target populations in the 12
MSAs. A new data collection activity is
proposed through this project to collect
information about behavioral and
clinical outcomes from injection drug
users, high-risk heterosexuals, and HIVpositive individuals who access medical
care in six of the 12 ECHPP-funded
MSAs. These MSAs are: District of
Columbia; Houston, TX; Los Angeles,
CA; Miami, FL; New York City, NY; and
San Francisco, CA. The purpose of this
new data collection activity is to
monitor community-level outcomes of
ECHPP and supplement HIV
surveillance data routinely collected in
these areas. Outcome data will be
collected in these MSAs at two time
points between 2012 and 2014.
Two surveys will be used in this
project: (1) A community-based survey
to be administered to injection drug
users and high-risk heterosexuals, and
(2) a clinic-based survey to be
administered to HIV-positive
individuals seeking care at clinics that
provide HIV-related services. Both
surveys will collect data on
demographics, sexual behavior, alcohol
and drug use history, HIV testing
experiences, exposure to HIV
prevention messages, and participation
in HIV prevention activities. The clinic
survey will also include questions about
HIV treatment, treatment adherence,
sources of care, and medical outcomes.
For the community survey, for each of
the two data collection periods, we
intend to recruit and screen 750
injection drug users and 750 high-risk
heterosexuals using venue-based,
convenience sampling methods. For the
clinic survey, we intend to recruit and
screen 1400 HIV-positive individuals
seeking HIV care at medical clinics. A
total of 600 eligible injection drug users
(age > 18 yrs), 600 eligible high-risk
heterosexuals (age 18 to 60 yrs), and
1200 eligible HIV-positive individuals
(age > 18 yrs) will be surveyed. CDC
will collaborate with local health
department staff and outreach workers
E:\FR\FM\20DEN1.SGM
20DEN1
78925
Federal Register / Vol. 76, No. 244 / Tuesday, December 20, 2011 / Notices
in each MSA to identify venues and
clinics appropriate for data collection.
Surveys will be administered by trained,
local interviewers. There is no cost to
respondents other than their time. The
total annual burden hours are 1,704.
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
respondents
Data collection form
Respondent
Project orientation ...........................................
Clinic Staff Script—Provision of Patient Loads
Clinic Staff Script—Approaching Clients ........
Clinic Screener ................................................
Clinic Survey ...................................................
Community Screener ......................................
Community Survey ..........................................
Community Screener ......................................
Community Survey ..........................................
Clinic staff .......................................................
Clinic staff .......................................................
Clinic staff .......................................................
HIV-positive individuals screened ..................
Eligible HIV-positive individuals .....................
Injection drug users screened ........................
Eligible injection drug users ...........................
High-risk heterosexual individuals screened
Eligible high-risk heterosexual individuals .....
Dated: December 14, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–32495 Filed 12–19–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-12–11AN]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
jlentini on DSK4TPTVN1PROD with NOTICES
Proposed Project
Asthma Education Study: Making
Health Care Providers Better Asthma
Educators—New-National Center for
Environmental Health (NCEH) and
Agency for Toxic Substances and
Disease Registry (ATSDR)/Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Department of Health and Human
Services (HHS), Centers for Disease
Control and Prevention (CDC) reports
that 17.5 million non-institutionalized
adults have asthma. In addition, 7.1
million children in this country have
VerDate Mar<15>2010
16:28 Dec 19, 2011
Jkt 226001
the disorder. Asthma accounts for 17
million health care visits and more than
3,400 deaths per year. All of these data
are for the United States. Except for a
few cases linked to occupational
exposures, the causes of asthma remain
unknown, and there exists no cure. In
the absence of means to eliminate the
disorder, treatment to minimize the
frequency and intensity of asthmatic
attacks is of paramount importance.
Several tools are available, including the
use of corticosteroids and control of
exposure to allergens and irritants,
collectively known as ‘‘triggers.’’ Thus,
treatment of asthma is important and
patients must take action at appropriate
times. From this, it follows that the
education provided by health care
providers to asthmatic patients forms a
critical link in efforts to control asthma.
CDC and the National Institutes of
Health recommend the use of written
asthma action plans to guide patient
self-management of the disorder. Some
states have also developed tools. In the
case of Minnesota, this is an interactive
program on the Internet.
Anecdotal evidence suggests that
there is substantial variability in the use
of available tools for developing written
asthma action plans. Similarly, patient
education appears to vary in type and
amount. Some causes of this are
suspected: Billing codes for asthma
education are not universally present
and the degree of health literacy among
patients varies and is likely not
universally sufficient. Nevertheless, in
large part, the factors influencing
asthma education by health care
providers are unknown. To help address
this situation, the Air Pollution and
Respiratory Health Branch of CDC
wishes to conduct a study to identify
barriers to, and facilitators of, asthma
education among health care providers
consistent with National Asthma
Education and Prevention Program
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
40
600
1,100
1,400
1,200
750
600
750
600
Number of
responses per
respondent
1
1
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
30/60
5/60
5/60
5/60
40/60
5/60
25/60
5/60
25/60
(NAEPP)/National Heart, Lung, and
Blood Institute Expert Panel Report 3:
Guidelines for the Diagnosis and
Management of Asthma.
Close to 25 million Americans
currently suffer with asthma, with 12
million experiencing an asthma ‘‘attack’’
in 2009, costing the nation $56 billion
and individuals on average over $3,200
annually in direct and indirect costs.
Improved self-management education,
consistent with the NIH/NAEPP
guidelines, for enhancing education of
persons with asthma in the areas of
correct medication adherence and
avoidance of environmental triggers of
asthma attacks, is central to reducing
the health burden and financial burden
on individuals and the nation. This
research is an important step in
improving the education individuals
with asthma (or parents of children with
asthma) receive at their initial diagnosis
encounter with the medical system. As
such it is expected to improve proper
medication adherence and avoidance of
environmental triggers of an asthma
attack and in turn to be of use to the
government in reducing both the
medical and financial burden of asthma
on the nation. In this aspect, this
research is directly in line with both the
mission of the CDC National Asthma
Control Program, its funder, which
seeks to achieve reductions in deaths
and hospitalizations and increases in
self-management education for
individuals with asthma and that
Program’s Government Performance and
Results Act Performance Measure:
Increase the proportion of those with
current asthma who report they have
received self–management training for
asthma in populations served by CDC
funded state asthma control programs.
The research project is also in alignment
with Healthy People 2020 objectives
including reducing asthma deaths
(objective RD–1), reducing
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 76, Number 244 (Tuesday, December 20, 2011)]
[Notices]
[Pages 78924-78925]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-32495]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-12-11DT]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
Monitoring Outcomes of the Enhanced Comprehensive HIV Prevention
Plan (ECHPP) Project -New- National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The scope of the HIV epidemic in the United States is significant,
particularly in large urban areas where HIV/AIDS cases are
concentrated. In 2006, approximately 56,000 new HIV infections occurred
in the U.S., demonstrating the need to expand targeted HIV prevention
efforts. In 2010, twelve U.S. metropolitan statistical areas (MSAs)
received funding, through their city and state health departments, to
conduct the Enhanced Comprehensive HIV Prevention Planning (ECHPP)
project. These twelve MSAs (Atlanta, GA; Baltimore, MD; Chicago, IL;
Dallas, TX; District of Columbia; Houston, TX; Los Angeles, CA; Miami,
FL; New York City, NY; Philadelphia, PA; San Francisco, CA; and San
Juan, PR) had the highest AIDS prevalence rates in the U.S. at the end
of 2007, representing 44% of all U.S. AIDS cases. The purpose of ECHPP
is to enhance existing HIV prevention services in these high prevalence
areas and provide an optimal mix of evidence-based behavioral,
biomedical, and structural interventions to have maximum impact on the
HIV/AIDS epidemic at the community level. ECHPP goals are consistent
with CDC's Division of HIV/AIDS Prevention Strategic Plan for HIV
Prevention and with the National HIV/AIDS Strategy: (1) Prevent new HIV
infections, (2) increase linkage to, and impact of, prevention and care
services for HIV-positive individuals, and (3) reduce HIV-related
health disparities.
To evaluate ECHPP's impact on the HIV/AIDS epidemic at the
community level, data will be collected through both existing CDC data
sources and through new data collection activities. Existing CDC data
sources will include HIV surveillance systems (e.g., National HIV
Behavioral Surveillance System, Medical Monitoring Project) that
routinely collect information about behavioral and clinical outcomes
from at-risk target populations in the 12 MSAs. A new data collection
activity is proposed through this project to collect information about
behavioral and clinical outcomes from injection drug users, high-risk
heterosexuals, and HIV-positive individuals who access medical care in
six of the 12 ECHPP-funded MSAs. These MSAs are: District of Columbia;
Houston, TX; Los Angeles, CA; Miami, FL; New York City, NY; and San
Francisco, CA. The purpose of this new data collection activity is to
monitor community-level outcomes of ECHPP and supplement HIV
surveillance data routinely collected in these areas. Outcome data will
be collected in these MSAs at two time points between 2012 and 2014.
Two surveys will be used in this project: (1) A community-based
survey to be administered to injection drug users and high-risk
heterosexuals, and (2) a clinic-based survey to be administered to HIV-
positive individuals seeking care at clinics that provide HIV-related
services. Both surveys will collect data on demographics, sexual
behavior, alcohol and drug use history, HIV testing experiences,
exposure to HIV prevention messages, and participation in HIV
prevention activities. The clinic survey will also include questions
about HIV treatment, treatment adherence, sources of care, and medical
outcomes. For the community survey, for each of the two data collection
periods, we intend to recruit and screen 750 injection drug users and
750 high-risk heterosexuals using venue-based, convenience sampling
methods. For the clinic survey, we intend to recruit and screen 1400
HIV-positive individuals seeking HIV care at medical clinics. A total
of 600 eligible injection drug users (age 18 yrs), 600
eligible high-risk heterosexuals (age 18 to 60 yrs), and 1200 eligible
HIV-positive individuals (age 18 yrs) will be surveyed. CDC
will collaborate with local health department staff and outreach
workers
[[Page 78925]]
in each MSA to identify venues and clinics appropriate for data
collection. Surveys will be administered by trained, local
interviewers. There is no cost to respondents other than their time.
The total annual burden hours are 1,704.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Data collection form Respondent respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Project orientation................... Clinic staff............ 40 1 30/60
Clinic Staff Script--Provision of Clinic staff............ 600 1 5/60
Patient Loads.
Clinic Staff Script--Approaching Clinic staff............ 1,100 1 5/60
Clients.
Clinic Screener....................... HIV-positive individuals 1,400 1 5/60
screened.
Clinic Survey......................... Eligible HIV-positive 1,200 1 40/60
individuals.
Community Screener.................... Injection drug users 750 1 5/60
screened.
Community Survey...................... Eligible injection drug 600 1 25/60
users.
Community Screener.................... High-risk heterosexual 750 1 5/60
individuals screened.
Community Survey...................... Eligible high-risk 600 1 25/60
heterosexual
individuals.
----------------------------------------------------------------------------------------------------------------
Dated: December 14, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-32495 Filed 12-19-11; 8:45 am]
BILLING CODE 4163-18-P
